Aura Biosciences, Inc. Common Stock

AURANASDAQ • USD
7.19 USD
↗ 0.08 (1.13%)🟢LIVE (AS OF 02:01 PM EST)
🟢Market: OPEN

AURA is currently priced at $7.19. Technicals currently rate "Strong Buy" while our fundamental analysis reads "Neutral". Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. On the valuation side, AURA appears attractively valued relative to sector peers across key multiples.

Technical & fundamental data as of Nov 13, 2026.

Open?$7.05
High?$7.29
Low?$6.55
Prev. Close?$7.11
Volume?326.7K
Avg. Volume?843.5K
VWAP?$7.16
Rel. Volume?0.39x
Bid / Ask
Bid?$7.18 × 200
Ask?$7.21 × 400
Spread?$0.03
Midpoint?$7.20
Valuation & Ratios
Market Cap?740.0M
Shares Out?104.1M
Float?92.4M
Float %?89.1%
P/E Ratio?N/A
P/B Ratio?2.57
EPS?-$1.32
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.
Employees
113
Market Cap
740.0M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed
2021-10-29
Address
80 GUEST STREET
BOSTON, MA 02135
Phone: (617)500-8864
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
100
Momentum?
65
Short Sent.?
48
Piotroski F-Score?0/9Weak
Altman Z-Score?9.97Safe
Confidence?48%Low
Full Fundamental Analysis →
Short InterestVery High
Short % of Float?11.33%High
Short Interest?10.5M
Days to Cover?13.7
Free Float92.4M
Avg Daily Volume765.4K
Settlement Date2026-10-30
Financial Health
Current Ratio?14.21Strong
Quick Ratio?14.21Strong
Cash Ratio?1.95Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
Peers
100
S&P
63
2.57CHEAP▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-4.8CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
3
-47.7%WEAK▾
ROA?
S&P
3
-42.6%WEAK▾
Cash Flow & Enterprise
FCF?$-109682000
Enterprise Value?$698.3M
Fundamentals ratios updated end of day